EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieValidierungsstudieOpen Access · CC BY-NC 3.0

Development and Validation of a Predictive Model for HBsAg Seroclearance After Peg-IFN-Based Therapy: A Multicentre Study

Hui-Hui Liu iD, Xue-Mei Jiang, Chao Cui iD, Jing Zhao, Juan Xu, Si-Kui Wang, Lei-Hua Hu, Yan-Ping Yin, Xiao Wang, Li-Jun Yu, Cheng Xu, Zheng-Hua Zhao und 4 weitere

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s545700 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Hui-Hui Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B Surface Antigens, Hepatitis B, Chronic, Interferon-alpha. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis B Surface AntigensHepatitis B, ChronicInterferon-alphaPolyethylene GlycolsAdultFemaleHumansMaleMiddle AgedCohort StudiesHepatitis B e AntigensRecombinant ProteinsRetrospective Studies

Stichwörter der Autor:innen

HBsAg seroclearancechronic hepatitis Bmulticentre studypegylated interferon alfapredictive model

Substanzen

Antiviral AgentsHepatitis B e AntigensHepatitis B Surface AntigensInterferon-alphaPolyethylene GlycolsRecombinant Proteins

Autor:innen und Institutionen

  • Department of Hepatology, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China.
  • Department of Hepatology, Shandong Public Health Clinical Center, Jinan, Shandong, People's Republic of China.
  • Department of Infectious Disease, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, People's Republic of China.
  • Department of Infectious Disease, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, People's Republic of China.
  • Department of Infectious Disease, Shengli Oilfield Central Hospital, Dongying, Shandong, People's Republic of China.
  • Department of Infectious Disease, Liaocheng People's Hospital, Liaocheng, Shandong, People's Republic of China.

ORCID-Profile: Hui-Hui Liu, Chao Cui, Yan-Qing Xing

Zitieren

APA

Liu, H. H., Jiang, X. M., Cui, C., Zhao, J., Xu, J., Wang, S. K., Hu, L. H., Yin, Y. P., Wang, X., Yu, L. J., Xu, C., Zhao, Z. H., Xing, Y. Q., Liu, Y., Wang, K., & Gao, S. (2025). Development and Validation of a Predictive Model for HBsAg Seroclearance After Peg-IFN-Based Therapy: A Multicentre Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s545700

Vancouver

Liu HH, Jiang XM, Cui C, Zhao J, Xu J, Wang SK, et al. Development and Validation of a Predictive Model for HBsAg Seroclearance After Peg-IFN-Based Therapy: A Multicentre Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s545700

BibTeX
@article{Liu2025,
  author = {Liu, Hui-Hui and Jiang, Xue-Mei and Cui, Chao and Zhao, Jing and Xu, Juan and Wang, Si-Kui and Hu, Lei-Hua and Yin, Yan-Ping and Wang, Xiao and Yu, Li-Jun and Xu, Cheng and Zhao, Zheng-Hua and Xing, Yan-Qing and Liu, Yue and Wang, Kai and Gao, Shuai},
  title = {Development and Validation of a Predictive Model for HBsAg Seroclearance After Peg-IFN-Based Therapy: A Multicentre Study},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s545700}
}
Kostenlos starten →